Particulate Matter Testing of Traditional Chinese Medicine (TCM) Injections

Particulate matter testing is a critical quality control procedure for Traditional Chinese Medicine (TCM) injections, ensuring that sub-visible particles remain within pharmacopoeial limits before administration to patients. This technical article explains the principles, sample types, testing items, analytical methods, and applications of particulate matter testing for TCM injectable products in accordance with the Chinese Pharmacopoeia, USP, and EP standards.

Technical Overview

Traditional Chinese Medicine (TCM) injections are sterile pharmaceutical preparations made from extracted and refined herbal materials, administered directly into the bloodstream via intravenous, intramuscular, or other parenteral routes. Because these products bypass the body's natural defense barriers, any insoluble particulate matter they contain enters the circulatory system directly and can pose serious clinical risks, including venous inflammation, pulmonary capillary embolism, granuloma formation, and anaphylactoid reactions.

Particulate matter testing, also known as sub-visible particle testing, is therefore a mandatory release test for TCM injections. In China, the test is performed in accordance with the Chinese Pharmacopoeia (ChP) General Chapter 0903 "Particulate Matter Test for Injections," with methodological equivalence to USP <788> and EP 2.9.19. TCM injections present unique analytical challenges compared with chemical drug injections: their formulations are complex matrices containing tannins, proteins, polysaccharides, saponins, and pigments, and many products are deeply colored, viscous, or prone to precipitation, all of which can interfere with instrumental particle counting and require careful method selection.

Testing Samples

Small-Volume TCM Injections (Below 100 mL)

These include ampoule and vial presentations of TCM injections with a nominal volume of less than 100 mL, such as cardiovascular and cerebrovascular injectable products. For these products, particle limits are expressed on a per-container basis, and multiple containers are typically pooled or tested individually to obtain statistically valid results.

Large-Volume TCM Infusions (100 mL and Above)

Large-volume parenteral preparations containing TCM extracts are tested with limits expressed as particles per milliliter. Due to the larger infusion volume, the clinical risk from cumulative particle load is significant, making strict particle control essential.

Sterile Powders for Injection (Lyophilized Products)

Lyophilized TCM powders, such as freeze-dried extracts for reconstitution, must be tested after dissolution with particle-free water or the designated diluent. The reconstitution procedure must be validated to avoid introducing extraneous particles during sample preparation.

Concentrated Solutions for Injection

Concentrated TCM injection solutions intended for dilution prior to administration are tested in their concentrated form, and additional compatibility studies with common diluents such as 0.9% sodium chloride or 5% glucose are often performed to evaluate particle formation after mixing.

Testing Items

The core testing items for particulate matter evaluation include:

• Count of particles equal to or larger than 10 μm per milliliter or per container
• Count of particles equal to or larger than 25 μm per milliliter or per container
• Optional characterization of smaller particle populations (2 μm and 5 μm) for research, comparability, or USP <787>/<789> purposes
• Morphological observation and identification of particles during method development or failure investigations
• Particle formation assessment in dilution compatibility and in-use stability studies

Under the light obscuration method, the pharmacopoeial acceptance limits are: for products of 100 mL or more, no more than 25 particles of 10 μm or greater and no more than 3 particles of 25 μm or greater per milliliter; for products below 100 mL, sterile powders, and concentrated solutions, no more than 6,000 particles of 10 μm or greater and no more than 600 particles of 25 μm or greater per container.

Under the microscopic count method, the corresponding limits are: for products of 100 mL or more, no more than 12 particles of 10 μm or greater and no more than 2 particles of 25 μm or greater per milliliter; for products below 100 mL, no more than 3,000 particles of 10 μm or greater and no more than 300 particles of 25 μm or greater per container.

Testing Methods

Light Obscuration Method

The light obscuration method (Method 1) employs a liquid particle counter in which the sample passes through a narrow, illuminated sensing zone. Each particle interrupts the light beam and generates a voltage pulse proportional to its cross-sectional area, allowing automated counting and sizing. The instrument is calibrated with certified standard particles traceable to national or international standards, in accordance with ISO 21501-4. Testing is performed in a controlled low-particle environment, and particle-free water is tested first to verify that background counts are acceptably low. A minimum of four test units is typically measured, and results are evaluated against pharmacopoeial limits after discarding or averaging procedures as prescribed by the relevant chapter.

Microscopic Count Method

The microscopic count method (Method 2) is the designated alternative when light obscuration is unsuitable, for example with deeply colored, opaque, viscous, or emulsion-type TCM products that scatter or absorb light abnormally. A measured volume of sample is filtered through a gridded membrane filter with a nominal pore size of 0.45 μm. The membrane is dried and examined under a calibrated microscope at approximately 100× magnification using a calibrated ocular micrometer. Particles equal to or larger than 10 μm and 25 μm are counted within the effective filtration area, and the counts are converted to particles per milliliter or per container. The method also permits morphological characterization of the particles, which is valuable for root-cause analysis.

Method Selection Considerations for TCM Products

Because many TCM injections are brown, red-brown, or otherwise intensely colored, light obscuration sensors may produce biased results due to absorbance interference. In such cases, the microscopic count method serves as the confirmatory or arbitrating technique. If the light obscuration result is questionable or marginally outside limits, the microscopic method may be applied per pharmacopoeial provisions. Sample handling precautions, such as gentle inversion rather than vigorous shaking, adequate degassing, and minimizing transfer steps, are essential to prevent artificial particle generation.

Applications

• Batch release testing for commercial TCM injection products prior to distribution
• Registration dossier support for new drug applications and post-approval changes submitted to NMPA, FDA, or EMA
• Long-term, accelerated, and in-use stability studies to monitor particle growth over the product shelf life
• Formulation and process optimization, including evaluation of filtration sequences, terminal sterilization, container-closure systems, and excipient interactions
• Dilution compatibility studies with infusion fluids commonly used in clinical practice
• Investigation of adverse drug reactions and product quality complaints involving suspected particle contamination
• Comparability studies after manufacturing site transfers or process scale-up

FAQ

Why is particulate matter testing particularly important for TCM injections? TCM injections contain complex mixtures of natural macromolecules, tannins, and pigments that can aggregate, precipitate, or interact with packaging components, generating insoluble particles. Since these products are administered intravenously, particles cannot be eliminated by the body's natural filtration mechanisms, making rigorous testing essential for patient safety.

Which method should be used for a colored TCM injection? Light obscuration is the default first-choice method, but for intensely colored or turbid products where optical interference is suspected, the microscopic count method should be used as the primary or confirmatory method.

How are sterile powders for injection prepared for testing? Each container is reconstituted with an appropriate volume of particle-free water or the labeled diluent, following the clinical use instructions, and the reconstituted solution is then tested by the standard procedure with limits applied per container.

What should be done if test results exceed pharmacopoeial limits? Exceeding results should trigger an investigation covering sampling and testing operations, environmental controls, container-closure integrity, filtration effectiveness, and raw material quality. Retesting and confirmatory microscopic examination are typically performed as part of the out-of-specification procedure.

How often must particle counters be calibrated? Liquid particle counters should be calibrated periodically with certified standard particles, with routine performance verification before each test session using particle-free water to confirm acceptably low background counts, ensuring traceability and data integrity.